Detection of Candida species in vaginal samples in a clinical laboratory setting

Infectious Diseases in Obstetrics and Gynecology

Volumn 13, Issue 2, 2005, Pages 63-67

  Trama, Jason P ^a   Adelson, Martin E ^a   Raphaelli, Israel ^a   Stemmer, Shlomo M ^b   Mordechai, Eli ^a  

^a LLC   (United States)

^b Women's Center for Continence   (United States)

Author keywords

Age; Candida; Detection rates; DNA

Indexed keywords

DNA;

ADOLESCENT; ADULT; AGED; ARTICLE; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CLINICAL LABORATORY; CONTROLLED STUDY; FEMALE; FUNGAL DETECTION; HUMAN; HUMAN TISSUE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SCHOOL CHILD; UNITED STATES; VAGINA SMEAR; VAGINITIS;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CANDIDA; CANDIDIASIS, VULVOVAGINAL; CHILD; DNA, FUNGAL; FEMALE; HUMANS; MIDDLE AGED; POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES; UNITED STATES; VAGINAL SMEARS; VAGINITIS;

EID: 22144482344     PISSN: 10647449     EISSN: None     Source Type: Journal    
DOI: 10.1080/10647440400025629     Document Type: Article

References (19)

1. Sobel JD. Vaginitis. N Engl J Med 1997;337(26):1896-1903.
2. Diagnosis of Candida vaginitis. J Fam Pract 1985;20(1): 19-20.
3. Geiger AM, Foxman B, Gillespie BW. The epidemiology of vulvovaginal candidiasis among university students. Am J Public Health 1995;85(8):1146-1148.
4. Geiger AM, Foxman B. Risk factors for vulvovaginal candidiasis: a case-control study among university students. Epidemiology 1996;7(2):182-187.
5. Sobel JD. Pathogenesis and epidemiology of vulvovaginal candidiasis. Ann N Y Acad Sci 1988;544:547-557.
6. Sobel JD. Vulvovaginitis in healthy women. Compr Ther 1999;25(6-7):335-346.
7. Horowitz BJ, Giaquinta D, Ito S. Evolving pathogens in vulvovaginal candidiasis: implications for patient care. J Clin Pharmacol 1992;32(3):248-255.
8. Pfaller MA, Diekema DJ, Messer SA, et al. Activities of fluconazole and voriconazole against 1586 recent clinical isolates of Candida species determined by broth microdilution, disk diffusion, and Etest methods: report from the ARTEMIS Global Antifungal Susceptibility Program, 2001. J Clin Microbiol 2003;41(4):1440-1446.
9. Snydman DR. Shifting patterns in the epidemiology of nosocomial Candida infections. Chest 2003;123(5):500-503.
10. Hazen KC. New and emerging yeast pathogens. Clin Microbiol Rev 1995;8(4):462-478.
11. Fidel Jr PL, Vazquez JA, Sobel JD. Candida glabrata: review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans. Clin Microbiol Rev 1999;12(1): 80-96.
12. Luo G, Mitchell TG. Rapid identification of pathogenic fungi directly from cultures by using multiplex PCR. J Clin Microbiol 2002;40(8):2860-2865.
13. Rex JH, Rinaldi MG, Pfaller MA. Resistance of Candida species to fluconazole. Antimicrob Agents Chemother 1995; 39(1):1-8.
14. Sobel JD, Faro S, Force RW, et al. Vulvovaginal candidiasis: epidemiologic, diagnostic, and therapeutic considerations. Am J Obstet Gynecol 1998;178(2):203-211.
15. Sobel JD. Pathogenesis and treatment of recurrent vulvovaginal candidiasis. Clin Infect Dis 1992;14(1):148-153.
16. Ginaldi L, Loreto MF, Corsi MP, et al. Immunosenescence and infectious diseases. Microbes Infect 2001;3(10):851-857.
17. Pawelec G, Solana R, Remarque E, et al. Impact of aging on innate immunity. J Leukoc Biol 1998;64(6):703-712.
18. Galgiani JN, Reiser J, Brass C, et al. Comparison of relative susceptibilities of Candida species to three antifungal agents as determined by unstandardized methods. Antimicrob Agents Chemother 1987;31(9):1343-1347.
19. Hazen KC, Baron EJ, Colombo AL, et al. Comparison of the susceptibilities of Candida spp. to fluconazole and voriconazole in a 4-year global evaluation using disk diffusion. J Clin Microbiol 2003;41(12):5623-5632.